Search research articles
Contact Us
Filters
Showing results (191-200 of 203) with videos related to
Page
of 21
Sort By:
Blood Cancer Journal
|
August 21, 2024
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial
Gianluca Cavallaro, Anna Grassi, Chiara Pavoni, et al.
The Lancet. Haematology
|
September 23, 2024
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial
Domenico Russo, Nicola Polverelli, Simona Bernardi, et al.
Haematologica
|
February 19, 2026
Real-world outcomes in refractory chronic graft-<i>versus</i>-host disease: the Italian multicenter experience with belumosudil
Francesca Bonifazi, Marcello Roberto, Maria Teresa Lupo Stanghellini, et al.
Frontiers in Immunology
|
February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Agnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi, et al.
Bone Marrow Transplantation
|
January 26, 2022
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT
Giorgia Battipaglia, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Blood
|
January 12, 2017
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
Reid W Merryman, Haesook T Kim, Pier Luigi Zinzani, et al.
Bone Marrow Transplantation
|
March 27, 2026
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT
Simone Cesaro, Chiara Garonzi, Gloria Tridello, et al.
Haematologica
|
September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Bhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 19, 2026
Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study
Michele Malagola, Domenica Matranga, Luca Castagna, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 203) with videos related to
Sort By:
Page
of 21
Blood Cancer Journal
|
August 21, 2024
Busulfan-fludarabine versus busulfan-cyclophosphamide for allogeneic transplant in acute myeloid leukemia: long term analysis of GITMO AML-R2 trial
Gianluca Cavallaro, Anna Grassi, Chiara Pavoni, et al.
The Lancet. Haematology
|
September 23, 2024
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial
Domenico Russo, Nicola Polverelli, Simona Bernardi, et al.
Haematologica
|
February 19, 2026
Real-world outcomes in refractory chronic graft-<i>versus</i>-host disease: the Italian multicenter experience with belumosudil
Francesca Bonifazi, Marcello Roberto, Maria Teresa Lupo Stanghellini, et al.
Frontiers in Immunology
|
February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies
Agnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 12, 2017
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
Corrado Girmenia, Alice Bertaina, Alfonso Piciocchi, et al.
Bone Marrow Transplantation
|
January 26, 2022
Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the EBMT
Giorgia Battipaglia, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Blood
|
January 12, 2017
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
Reid W Merryman, Haesook T Kim, Pier Luigi Zinzani, et al.
Bone Marrow Transplantation
|
March 27, 2026
Incidence and outcome of hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: a survey of the infectious diseases working party of EBMT
Simone Cesaro, Chiara Garonzi, Gloria Tridello, et al.
Haematologica
|
September 21, 2019
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Bhagirathbhai Dholaria, Bipin N Savani, Myriam Labopin, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 19, 2026
Treatment of Acute Myeloid Leukemias and Myelodisplastic Syndromes Relapsing After Allogeneic Stem Cell Transplantation: An In-Depth Analysis of the GITMO AML/MDS-Relapse Registry Study
Michele Malagola, Domenica Matranga, Luca Castagna, et al.
Page
of 21